Hematologic Cancer

These guidelines and other documents provide advice for different types of hematologic cancer: non-Hodgkin lymphoma, leukemia, multiple myeloma, Hodgkin lymphoma, myelodysplastic syndrome (MDS) and myelofibrosis.

CAR T-cell Therapy Enrolment

Displaying Guidelines

9 articles

Acute Leukemia Provincial Plan

Document Status: Current
ID: GL-C50-34

Aug 2017

An Endorsement of the 2022 NCCN Guideline on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Document Status: Current
ID: GL-END-C50-35

Aug 2023

Best Practices for Pathology Secondary Review: Hematologic Cancers

Document Status: Archived
ID: 22-2-6

Jun 2014

Complex Malignant Hematology Models of Care: Recommendations for Changes in the Roles and Composition of the Multidisciplinary Team and the Setting of Care to Improve Access for Patients in Ontario – March 2017

Document Status: Current
ID: GL-C50-31

Mar 2017

Consensus Diagnostic and Prognostic Testing for Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: Recommendations Report - 2024

Document Status: Current
Version: 1.0

Jan 2024

Consensus Pathology Recommendations for Complex Malignant Hematology – December 2016

Document Status: Current
ID: GL-C50-28

Dec 2016

Minimal Residual Disease Testing in Acute Leukemia

Document Status: Current
ID: MOTAC-6
Version: 2

Sep 2020

Organizational Requirements for Acute Leukemia Service Providers in Ontario: Recommendations Report 2024

Document Status: Current
Version: 2

Dec 2024

PET Imaging in Lymphoma

Document Status: Current
ID: PET 12

Mar 2015